Estrogenized HSA induced high-affinity autoantibodies in breast cancer - Novel biomarker for early detection
Subuhi Sherwani, Mohd Wajid Ali Khan, Wahid Ali Khan, Saravanan Rajendrasozhan, Khalid Al-Motair, Hamda Khan, Saheem Ahmad · 2024
Read Estrogenized HSA induced high-affinity autoantibodies in breast cancer - Novel biomarker for early detection by Subuhi Sherwani, Mohd Wajid Ali Khan, Wahid Ali Khan, Saravanan Rajendrasozhan, Khalid Al-Motair, Hamda Khan, Saheem Ahmad (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11631743.txt.
Description
Subuhi Sherwani and co-authors present a 2024 study on a possible early warning sign for breast cancer. Estrogen can attach to blood proteins and change their shape. The immune system may then make antibodies against the altered protein, and those antibodies could flag the disease before symptoms appear.
The team bonded a form of estrogen to human serum albumin in the lab. Tests measured how strongly patients' antibodies gripped the altered protein. The group covered 85 breast cancer patients and 45 healthy controls. Patients carried high-affinity antibodies against the estrogen-bound protein. Binding tests also showed the altered protein behaved differently with its usual partners. The authors propose the antibody as a candidate marker for early detection.
Catalog record
| CREATOR | Subuhi Sherwani, Mohd Wajid Ali Khan, Wahid Ali Khan, Saravanan Rajendrasozhan, Khalid Al-Motair, Hamda Khan, Saheem Ahmad |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |